GB

Geoffrey Brooke

Cynata Therapeutics Limited | Non-Executive Director, Non-Executive Chairman
Dr Brooke has over 30 years of healthcare venture capital management and investment experience. Dr Brooke has also served as director of Cynata Therapeutics Ltd (ASX:CYP) since May 2019, where he currently serves as the non-executive chair of the board, Actinogen Medical Ltd (ASX:ACW) since March 2017, where he currently serves as non-executive chair of the board, and Acrux Ltd (ASX:ACR) since June 2016. He is also a member of corporate Governance committee.

Companies and Roles

Company
Title
Tenure
Since
CYP
CYP
Cynata Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
7yrs, 1mthMay 2019
ACW
ACW
Actinogen Medical Limited
  • Non-Executive Chairman
  • Non-Executive Director
5yrs, 5mthFeb 2021
SLD
SLD
Saluda Medical, Inc.
  • Non-Executive Director
5yrs, 8mthOct 2020
ACR
ACR
Acrux Limited
  • Non-Executive Director
10yrs, 1mthJun 2016

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ACW
ACW
Actinogen Medical Limited
24/06/2631,500,0005,825,8902,351,593N/A
CYP
CYP
Cynata Therapeutics Limited
29/11/25N/A312,898500,000N/A
ACR
ACR
Acrux Limited
30/06/251,296,080679,935285,714N/A
SLD
SLD
Saluda Medical, Inc.
20/10/20N/AN/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ACW
ACW
Actinogen Medical Limited
24/06/26
Issued
9,000,000$0.046$409,500Issued under employee share plan
ACW
ACW
Actinogen Medical Limited
26/03/26
Issued
1,357,857$4.200$5,702,999Placement
ACR
ACR
Acrux Limited
03/12/25
Issued
2,866,719$0.016$45,867Issue of securities
CYP
CYP
Cynata Therapeutics Limited
01/04/25
Expiry
69,767$0.205$14,302Options expired
ACW
ACW
Actinogen Medical Limited
24/03/25
Issued
8,000,000$0.043$340,000Issued under employee share plan